Page 1
175
REFERENCES
1. Aevarsson, O. and Skoog, I. “A longitudinal population study of
the minimental state examination in the very old: relation to
dementia and education”, Dement Geriatr Cogn Disord, Vol. 11,
pp. 166-75, 2000.
2. Albert, M.S. and Moss, M.B. “Geriatric Nemopsychology”,
Guilford Press, New York, pp. 33-56, 1988.
3. Alexopoulos, P., Grimmer, T., Perneczky, R., Domes, G. and
Kurz, A. “Progression to dementia in clinical subtypes of mild
cognitive impairment”, Dement Geriatr Cogn Disord, Vol. 22,
No.1, pp. 27-34, 2006.
4. Andreasen, N., Vanmechelen, E., Vanderstichele, H., Davidsson,
P. and Blennow, K. “Cerebrospinal fluid levels of total-tau,
phospho-tau and A beta 42 predicts development of Alzheimer's
disease in patients with mild cognitive impairment”, Acta Neurol
Scand issue, 179, pp. 47-51, 2003.
5. Anstey, K. and Christensen, H. “Education, activity, health, blood
pressure and apolipoprotein E as predictors of cognitive change
in old age: a review”, Gerontology, Vol. 46, pp. 163-177, 2000.
6. Anthony, J.C., LeResche, L. and Niaz, U. “Limits of the Mini-
Mental State as a screening test for dementia and delirium among
hospital patients”, Psychol Med, Vol. 12, pp. 397-408, 1982.
7. Apter, N.S., Halstead, W.C. and Heimburger, R.F. “Impaired
cerebral functions in essential hypertension”, American Journal
of Psychiatry, Vol. 107, pp. 808-813, 1951.
8. Arvanitakis, Z., Wilson, R.S., Li, Y., Aggarwal, N.T. and
Bennett, D.A. “Diabetes and function indifferent cognitive
systems in older individuals without dementia”, Diabetes Care,
Vol. 29, pp. 560-565, 2006.
Page 2
176
9. Arvanitakis, Z., Wilson, R.S., Bienias, J.L., Evans, D.A. and
Bennett, D.A. “Diabetes Mellitus and Risk of Alzheimer Disease
and Decline in CognitiveFunction”, Archives of Neurology,
Vol. 61, No. 5, pp. 661-666, 2004.
10. Assisib, M., Alimentib, F., Maceliab, S., Di Pietroab, G.,
Lalloniab, P. and Montera “Diabetes and cognitive function:
preliminary studies”, Archives of Gerontology and Geriatrics,
Vol. 22, No. 1, pp. 229-232, 1996.
11. Backman, L. and MacDonald, S.W.S “Death and cognition
desynthesis and outlook”, Eur Psychol, Vol. 11, No. 44, pp. 224-
235, 2006.
12. Baker, L. and Barcai, A. “Psychosomatic aspects of diabetes
mellitus”, In Modern Trends in Pspchosomntic Medicine (Edited
by 0. W. HILL), Butterworths, London, 1970.
13. Barclay, L.L., Weiss, E.M., Mattis, S., Bond, O. and Blass, J.P.
“Unrecognizedcognitive impairment in cardiac rehabilitation
patients”, Journal of the American Geriatrics Society, Vol. 36,
No. 1, pp. 22-28, 1988.
14. Beasers, B. “Teaching the diabetic patient”, Dioberes, Vol. 5,
pp. 146-149, 1956.
15. Becker, M.H. “Sociobehavioural determinants of compliance”, In
Compliance with Therapeutic Regimens (Edited by D. L. Sacket
and R. B. Haynes), Johns Hopkins Press. London, 1976.
16. Biessels, G.J. “Cerebral complications of diabetes: clinical
findings and pathogenetic mechanisms”, The Netherlands Journal
of Medicine, Vol. 54, No. 2, pp. 35-45, 1999.
17. Blennow, K. “CSF biomarkers for mild cognitive impairment”,
Journal of Internal Medicine, Vol. 256, No. 3, pp. 224-234, 1990.
18. Blennow, K. “Cerebrospinal fluid protein biomarkers for
Alzheimer's disease”, NeuroRx, Vol. 1, No. 2, pp. 213-225, 2004.
19. Blennow, K., Wallin, A., Uhlemann, C. and Gottfries, C. “White-
matter lesions on CT in Alzheimer patients: relation to clinical
Page 3
177
symptomatology and vascular factors”, Acta Neurol Scand,
Vol. 83, pp. 187-193, 1991.
20. Bloom, A. “Relation of the complications of diabetes to the
clinical state”, Proceedings of Royal Society of Medicine,
Vol. 60, pp. 149-152, 1967.
21. Blotnerh “Attempted suicide with insulin”, American Journal of
Medicinal Science, Vol. 227, pp. 387-390, 1954.
22. Blumenthal, H.T. “The aging-disease dichotomy: true or false?”,
Journals of Gerontology, Medical Sciences, Vol. 58, No. 2,
pp. 138-145, 2003.
23. Bowen, J., Teri, L., Kukull, W., McCormick, W., McCurry, S.M.
and Larson, E.B. “Progression to dementia in patients with
isolated memory loss”, Lancet, Vol. 349, No. 9054, pp. 763-765,
1997.
24. Bradley, C. Psychophysiological aspects of stress in diabetic
patients, Ischemic heart disease patients and healthy subjects,
Unpublished Ph.D. Thesis, University of Nottingham, 1978.
25. Bradley, C. “Life events and the control of diabetes mellitus”,
Journal Psychosom., Vol. 23, pp. 159-162, 1979.
26. Brandt, J., Spencer, M. and Folstein, M. “The Telephone
Interview for Cognitive Status”, Neuropsychiatry Neuropsychol.
Behavioural Neurology, Vol. 1, pp. 111-117, 1988.
27. Brandt, J., Spencer, M. and Folstein, M. “The Telephone
Interview for Cognitive Status”, Neuropsychiatry, Journal of
Psychiatry, Vol. 180, pp. 161 -167, 1983.
28. Breteler, M., Claus, J., Van Duijn, C., Launer, L. and Hofman, A.
“Epidemiology of Alzheimer's disease”, Epidemiol., Vol. 14,
pp. 59-82, 1992.
29. Broadhursat “Applications of the psychology of decisions. In
Theoretical and Experimental Bases of the Behuviour Therapies”
(Edited by M. P. Feldmanand A. Broadhurst), Wiley, London,
1976.
Page 4
178
30. Brun, A. and Englund, E. “A white matter disorder in dementia of
the Alzheimer type: a pathoanatomical study”, Annuals
Neurology, Vol. 19, pp. 253-262, 1986.
31. Butler, S.M., Ashford, J.W. and Snowdon, D.A. “Age, education,
and changes in the Mini-Mental State Exam scores for older
women: Findings from the Nun Study”, Journal of the American
Geriatrics Society, Vol. 44, No. 6, pp. 675-681, 1996.
32. Caballol, N., Marti, M.J. and Tolosa, E. “Cognitive dysfunction
and dementia in Parkinson disease”, Movement Disorders,
Vol. 22, No. 17, pp. 358-366, 2007.
33. Cacioppo, J.T. and Petty, R.E. “The need for cognition”, Journal
of Personality and Social Psychology, Vol. 42, pp. 116-131,
1982.
34. Cauley, J.A., Dorman, J.S. and Ganguli, M. “Genetic and aging
epidemiology.The merging of two disciplines”, Neurologic
Clinics, Vol. 14, No. 2, pp. 467-475, 1996.
35. Centers for Disease Control and Prevention, Alzheimer's
Association “The Healthy Brain Initiative: a National Public
Health Road Map to Maintaining Cognitive Health”, Alzheimer's
Association, Chicago, IL, 2007.
36. Chamberlain, S.R., Blackwell, A.D., Fineberg, N.A., Robbins,
T.W. and Sahakian, B.J. “The neuropsychology of obsessive
compulsive disorder: the importance of failures in cognitive and
behavioural inhibition as candidate endophenotypic markers”,
Neuroscience and Biobehavioural Reviews, Vol. 29, No. 3,
pp. 399-419, 2005.
37. Chen, P., Ratcliff, G., Belle, S.H., Cauley, J.A., DeKosky, S.T.
and Ganguli, M. “Cognitive tests that best discriminate between
presymptomatic AD and those who remain nondemented”,
Neurology, Vol. 55, No. 12, pp. 1847-1853, 2000.
38. Chitra, V., Venkata K.R.CH.H. Varma, P., Krishna raju, M.V.R.
and Jeya Prakash, K. “Study of Antidiabetic and free radical
scavenging activity of the seed extract of strychnos nuxvomica”,
International Journal of Pharmacy and Pharmaceutical Sciences,
Vol. 2, No. 1, 2010.
Page 5
179
39. Coffey, C.E., Saxton, J.A., Ratcliff, G., Bryan, R.N. and Lucke,
J.F. “Relation ofeducation to brain size in normal aging:
implications for the reservehypothesis”, Neurology, Vol. 53,
No. 1, pp. 189-196, 1999.
40. Colcombe, S.J., Kramer, A.F., Erickson, K.I., Scalf, P., McAuley,
E. and Cohen, N.J. “Cardiovascular fitness, cortical plasticity,
and aging”, Proceedings of National Academy of Science of the
United States of America, Vol. 101, pp. 3316-3321, 2004.
41. Convit, A., Wolf, O.T., Tarshish, C. and de Leon, M.J. “Reduced
glucosetolerance is associated with poor memory performance
and hippocampalatrophy among normal elderly”, Proceedings of
the National Academy of Sciences of the United States of
America, Vol. 100, No. 4, pp. 2019-2022, 2003.
42. Cossa, F.M., Sala, S.D., Musicco, M., Spinnler, H. and Ubezio,
M.C. “The Milan overall dementia assessment and the mini-
mental state examination compared: an epidemiological
investigation of dementia”, European Journal of Neurolgia,
Vol. 6, pp. 289-294, 1999.
43. Craft, S., Dagogo-Jack, S.E., Wiethop, B.V., Murphy, C., Nevins,
R.T. and Fleischman, S. “Effects of hyperglycemia on memory
and hormone levels in dementia of the Alzheimer type: a
longitudinal study”. Behavioural Neuroscience, Vol. 107, pp.
926-940, 1993.
44. Craft, S., Newcomer, J., Kanne, S., Dagogo-Jack, S., Cryer, P.,
Sheline, Y., Luby, J., Dagogo-Jack, A. and Alderson, A.
“Memory improvement following induced hyperinsulinemia in
Alzheimer's disease”, Neurobiology of Aging, Vol. 17, pp. 123-
130, 1996.
45. Crowell, D. “Personality and physical disease: a test of the
Dunbdr hypothesis applied to diabetes mellitus and rheumatic
fever”, Genetic Psychology Monographs, Vol. 48, No. 1953, pp.
117-153, 1953.
46. Croxson, S.C.M. and Jagger, C. “Diabetes and Cognitive
Impairment - a Community based Study of Elderly Subjects”,
Age and Ageing, Vol. 24, No. 5, pp. 421-424, 1995.
Page 6
180
47. Crum, R.M., Anthony, J.C. and Bassett, S.S. “Population-based
norms for the Mini-Mental State Examination by age and
educational level”, Journal of American Medical Association,
Vol. 269, pp. 2386-2391, 1993.
48. Cukierman, T., Gerstein, H.C. and Williamson, J.D. “Cognitive
decline and dementia indiabetes-systematic overview of
prospective observational studies”, Diabetologia, Vol. 48,
pp. 2460-2469, 2005.
49. Cunningham, W.R. “Intellectual abilities and age”, Schaie KW,
Ed., Annual Review of Gerontology and Geriatrics, Vol. 7, New
York: Springer, pp. 117-134, 1984.
50. Debling, D., Manfred Amelang, Petra Hasselbach and Til
Sturmer, “Diabetes and cognitive function in a population-based
study of elderly women and men”, Journal of Diabetes and its
Complications, Vol. 20, No. 4, pp. 238-245, July 2006.
51. Diabetes-Atlas, Diabetes Atlas 3, http://www.eatlas.idf.org/
media, 2008.
52. DiMatteo M. Robin, Haskard, B. Kelly and Williams, L. Summer
“Health Beliefs, Disease Severity, and Patient Adherence: A
Meta-Analysis”, Medical Care, Vol. 45, No. 6, pp. 521-528, June
2007.
53. Dunbar-Jacob, J. and Mortimer-Stephens, M.K. “Treatment
adherence in chronic disease”, Journal of Clinical
Epidemiology”, Vol. 54, No. 12, Supplement 1, pp. S57-S60,
December 2001.
54. Dunstan, D.W., Zimmet, P.Z., Welborn, T.A., De Courten, M.P.,
Cameron, A.J. and Sicree, R.A. “The rising prevalence of
diabetes and impairedglucose tolerance: the Australian Diabetes,
Obesity and Lifestyle Study”, Diabetes Care, Vol. 25, No. 5,
pp. 829-834, 2002.
55. Earles, J.L. and Salthouse, T.A. “Interrelations of age, health, and
speed”, Journals of Gerontology: Psychological Sciences,
Vol. 50, No. 1, pp. 33-41, 1995.
Page 7
181
56. Elias, P.K., Elias, M.F., D'Agostino, R.B., Cupples, L.A., Wilson,
P.W. and Silbershatz, H. “NIDDM and blood pressure as risk
factors for poor cognitive performance”, The Framingham Study.
Diabetes Care, Vol. 20, No. 9, pp. 1388-1395, 1997.
57. Elias, P.K., Elias, M.F., Robbins, M.A. and Budge, M.M. “Blood
pressurerelated cognitive decline: does age make a difference?”
Hypertension, Vol. 44, pp. 631-636, 2004.
58. Elias, M.F., Elias, P.K., Sullivan, L.M., Wolf, P.A. and
Agnostino, R.B.D. “Lower cognitive function in the presence of
obesity and hypertension - The Framingham Heart Study”,
International Journal of Obesity and Relative Metabolic Disorder,
Vol. 27, pp. 260-268, 2003.
59. Etzwiler, D.D. and Robb, J.R. “Evaluation of programmed
education among juvenile diabetics and their families”, Diabetes,
Vol. 21, pp. 967-971, 1972.
60. Etzwiler, D.D. and Sines, L.K. “Juvenile diabetes and its
management: Family, social and academic implications”, Journal
of American Medical Association, Vol. 28, pp. 304-308, 1967.
61. Etzwiler, D.D. “What the juvenile diabetic knows about his
disease”, Prdiurrics, Vol. 29, pp. 135-141, 1962.
62. Fabre, C., Chamari, K., Mucci, P., Masse-Biron, J., Prefaut, C.
“Improvement of cognitive function by mental and/or
individualized aerobic training in healthy elderly subjects”,
International Journal of Sports Medicine, Vol. 23, pp. 415-421,
2002.
63. Fanelli, C., Pampanelli, S., Epifano, L., Rambotti, A.M., Ciofetta,
M. and Modarelli, F. “Relative roles of insulin and
hypoglycaemia on induction of neuroendocrine responses to,
symptoms of and deterioration of cognitive function in
hypoglycaemia in male and female humans”, Diabetologia,
Vol. 37, pp. 797-807, 1994.
64. Ferraro, K.F. “Double jeopardy to health for black older adults?”,
Journal of Gerontology, Vol. 42, No. 5, pp. 528-533.
Page 8
182
65. Fleg, J.L. “Alterations in cardiovascular structure and function
with advancing age”, American Journal of Cardiology, Vol. 57,
pp. 33-44, 1986.
66. Folstein, M.F., Folstein, S.E. and Mc Hugh, P.R. “Mini-mental-
state. A practical method for grading the cognitive state of
patients for clinician”, Journal of Psychiatry, Vol. 12, pp. 189-
198, 1975.
67. Fowlerj, E., Buuzyns, L., Ti, H. and Vani-enbergrh, L. “Effects of
EMG Biofeedback Relaxation Program on the control of
diabetes”, Eiofeed Seorg, Vol. 1, pp. 105- 112, 1976.
68. Fratiglioni, L., Paillard-Borg, S. and Winblad, B. “An active and
socially integrated lifestyle in late life might protect against
dementia”, Lancet Neurolgia, Vol. 3, pp. 343-353, 2004.
69. Gallo, J.J. “Epidemiology of mental disorders in middle age and
late life”, Conceptual issues, Epidemiology, Vol. 17, pp. 83-94,
1995.
70. Gavin, J.R., Alberti, K., Davidson, M.B., DeFronzo, R.A., Drash,
A. and Gabbe, S.G. “Report of the Expert Committee on the
diagnosis and classification of diabetes mellitus”, Diabetes Care,
Vol. 23, pp. S4-S19, 200.
71. Gold, P.E. and Stone, W.S. “Neuroendocrine Effects on Memory
in Aged Rodents and Humans”, Neurobiology of Aging, Vol. 9,
pp. 709-717, 1988.
72. Gold, JoAnn Vogt, Jeremy, L. and Paul, E. “Glucose effects on
memory: Behavioral and pharmacological characteristics”,
Behavioral and Neural Biology, Vol. 46, No. 2, September 1986,
pp. 145-155.
73. Gonder-Fredrik, L., Hall, J.L., Vogt, J., Cox, D.J., Green, J. and
Gold, P.E. “Memory enhancement in elderly humans: effects of
glucose ingestion”, Physiology of Behaviour, Vol. 41, pp. 503-
504, 1987.
74. Goshorn, R.K. “Chronic fatigue syndrome: a review for
clinicians”, Seminar Neurology, Vol. 18, No. 2, pp. 237-242,
1998.
Page 9
183
75. Graber, A.L., Christman B.G., Alogna, M.T. and Davidson, J.K.
“Evaluation of diabetes patienteducation programmes”, Diuheres,
Vol. 26, pp. 61-64, 1977.
76. Grant, I. and Kyle, G.C., Teichman, A. and Mendels, J. “Recent
life events and diabetes in adults”, P.qvchosom. Medicine,
Vol. 36, pp. 121-128, 1974.
77. Green, R.W. “Self-regulated eating behaviours in a diabetic
mental patient”, Behavioural Therapy, Vol. 9, p. 525, 1978.
78. Grodstein, F., Chen, J., Wilson, R.S. and Manson, J.E. “Type 2
diabetes and cognitive functionin community-dwelling elderly
women”, Diabetes Care, Vol. 24, pp. 1060-1065, 2001.
79. Guarch, J., Marcos, T., Salamero, M. and Blesa, R.
“Neuropsychological markers of dementia in patients with
memory complaints”, International Journal of Geriatry and
Psychiatry, Vol. 19, No. 4, pp. 352-358, 2004.
80. Hale, T.S., Zaidel, E., McGough, J.J., Phillips, J.M. and
McCracken, J.T. “Atypical brain laterality in adults with ADHD
during dichotic listening for emotional intonation and words”,
Neuropsychologia, Vol. 44, No. 6, pp. 896-904, 2006.
81. Hall, K.S., Gao, S., Unverzgat, F.W. and Hendrie, H.C. “Low
education and childhood rural residence: risk for Alzheimer’s
disease in AfricanAmericans”, Neurology, Vol. 54, pp. 95-99,
2000.
82. Hansson, O., Zetterberg, H., Buchhave, P., Londos, E., Blennow,
K. and Minthon, L. “Association between CSF biomarkers and
incipient Alzheimer's disease in patients with mild cognitive
impairment: a follow-up study”, Lancet Neurolgia, Vol. 5, No. 3,
pp. 228-234, 2006.
83. Hassing, L.B., Hofer, S.M., Nilsson, S.E., Berg, S., Pedersen,
N.L. and McClearn, G., “Comorbid type 2 diabetes mellitus and
hypertension exacerbatescognitive decline: evidence from a
longitudinal study”, Age and Ageing, Vol. 33, No. 4, pp. 355-
361, 2004.
Page 10
184
84. Haynes, D.L. and Sackett, R.B. “Compliance with Therapeutic
Regimens”, Johns Hopkins University Press, London, 1976.
85. Hendrie, H.C., Albert, M.S. and Butters, M.A. “The NIH
Cognitive and Emotional Health Project: report of the Critical
Evaluation Study Committee”, Alzheimer's Dementia, Vol. 2,
pp. 12-32, 2006.
86. Henriksson, F., Agardh, C.D., Berne, C., Bolinder, J., Lonnqvist,
F. and Stenstrom, P. “Direct medical costs for patients with type
2 diabetes in Sweden”, Journal of Internal Medicine, Vol. 248,
No. 5, pp. 387-396, 2000.
87. Herukka, S.K., Helisalmi, S., Hallikainen, M., Tervo, S.,
Soininen, H. and Pirttila, T. “CSF Abeta42, Tau and
phosphorylated Tau, APOE epsilon4 allele and MCI type in
progressive MCI”, Neurobiology of Aging, Vol. 28, No. 4,
pp. 507-514, 2007.
88. Hinkle, L.E. and Wolf, S. “Importance of life stress in course and
management of diabetes mellitus”, Journal of American Medical
Association, Vol. 148, pp. 513-520, 1952.
89. Hitt, R., Young-Xu, Y., Silver, M. and Perls, T. “Centenarians:
the older you get, the healthier you have been”, Lancet, Vol. 354,
No. 9179, pp. 652, 1999.
90. Ho, S.C., Woo, J., Sham, A., Chan, S.G. and Yu, A.L.M. “A 3-
year follow-up study of social, lifestyle and health predictors of
cognitive impairment in a Chinese older cohort”, International
Journal of Epidemiology, Vol. 30, pp. 1389-1396, 2001.
91. Hogan, P., Dall, T. and Nikolov, P. “For the American Diabetes
Association. Economic costs of diabetes in the US”, Diabetes
Care, Vol. 2003, No. 26, pp. 917-932, 2002.
92. Horn, J.L. “Intellectual stability concepts”, In: Steinberg, R.J.
(Ed.), Advances in the Psychology of Human Intelligence,
Erlbaum, Hillsdale, NJ, pp. 35-77, 1986.
93. Hsu, H.C. “Does social participation by the elderly reduce
mortality and cognitive impairment”, Aging and Mental Health,
Vol. 11, pp. 699-707, 2007.
Page 11
185
94. Hulka, B.S., Kupper, L., Cassel, J.C. and Mayo, F. Doctor-patient
communication and outcomes among diabetic patients, Journal of
Community Health, Vol. 1, pp. 15-20, 1975.
95. Hultsch, D.F., Hertzog, C., Small, B.J., McDonald-Miszczak, L.
and Dixon, R.A. “Short-term longitudinal change in cognitive
performance in later life”, Psychology of Aging, Vol. 7, pp. 571-
584, 1992.
96. Ivanoiu, A. and Sindic, C.J. “Cerebrospinal fluid TAU protein
and amyloid beta 42 in mild cognitive impairment: prediction of
progression to Alzheimer's disease and correlation with the
neuropsychological examination”, Neurocase, Vol. 11, No. 1,
pp. 32-39, 2005.
97. Jama Warsama, J., Launer, L.J., Witteman, J.C.M., den Breeijen,
J.H., Breteler, M.M.B., Grobbee, D.E. and Hofman, A. “Dietary
Antioxidants and Cognitive Function in a Population-based
Sample of Older Persons, The Rotterdam Study”, American
Journal of Epidemiology, Vol. 144, No. 3, pp. 275-280, 1996.
98. Janis, I.L. “Stages in the decision making process, In Theories OJ
Coynirice Consistency: A Source Book”, (Edited by R. P.
Arelwnet -11.)R. and McNally, Chicago, 1968.
99. Janis, I.K. and King, B.T. “The influence of role playing on
opinion change”, Journal of Abnormal Psychology, Vol. 49,
pp. 211-218, 1954.
100. Jansen, C.E., Miaskowski, C.A., Dodd, M.J. and Dowling, G.A.
“A meta-analysis of the sensitivity of various neuropsychological
tests used to detect chemotherapy-induced cognitive impairment
in patients with breast cancer”, Oncology and Nursing Forum,
Vol. 34, No. 5, pp. 997-1005, 2007.
101. Janssen, I., Katzmarzyk, P.T. and Ross, R. “Waist circumference
and not bodymass index explains obesity-related health risk”,
American Journal of Clinical Nutrition, Vol. 79, No. 3, pp. 379-
384, 2004.
102. Jasmanda H. Wu, Mary N. Haan, Jersey Liang, P.H., Debashis
Ghosh, Hector M. Gonzalez and William H. Herman, “Impact of
Antidiabetic Medications on Physical and Cognitive Functioning
Page 12
186
of Older Mexican Americans with Diabetes Mellitus: A
Population-based Cohort Study”, Annals of Epidemiology,
Vol. 13, No. 5, pp. 369-376, May 2003.
103. Jason, L.A., Corradi, K., Torres-Harding, S., Taylor, R.R. and
King, C. “Chronicfatigue syndrome: the need for subtypes”,
Neuropsychological Rev, Vol. 15, No. 1, pp. 29-58, 2005.
104. Joyce, E.M. and Roiser, J.P. “Cognitive heterogeneity in
schizophrenia”, Current Openion on Psychiatry, Vol. 20, No. 3,
pp. 268-272, 2007.
105. Juva, K., Sulkava, R., Erkinjuntti, T., Valvanne, J., Tilvis, R.
“Prevalence of dementia in the city of Helsinki”, Acta Neurol
Scand, Vol. 87, pp. 106-110, 1993.
106. Kaiyala, K.J., Prigeon, R.L., Kahn, S.E., Woods, S.C. and
Schwartz, M.W. “Obesity induced by a high-fat diet is associated
with reduced brain insulin transport in dogs”, Diabetes, Vol. 49,
No. 9, pp. 1525-1533, 2000.
107. Kalmijn, S., Feskens, E.J.M., Launer, L.J., Stijnen, T., Kromhout,
D. “Glucose intolerance, hyperinsulinaemia and cognitive
function in a general population of elderly men”, Diabetologia,
Vol. 38, pp. 1096-1102, 1995.
108. Kalmijn, S., Launer, L.J., Alewijn Ott, A., Witteman, J.C., and
Breteler, M.M. “Dietary fat intake and the risk of incident
dementia in the Rotterdam study”, Annals of Neurology, Vol. 42,
No. 5, pp. 776-782, November 1997.
109. Kang, J.H., Ascherio, A. and Grodstein, F. “Fruit and vegetable
consumption and cognitive decline in aging women”, Anual of
Neurolgia, Vol. 57, pp. 713-720, 2005.
110. Karp, A. “Mental, physical and social components in leisure
activities equally contribute to decrease dementia risk”, Dementia
and Geriatric Cognitive Disorder, Vol. 21, pp. 65-73, 2006.
111. Katzman, I.L. “Education and the prevalence of dementia and
Alzheimer’s disease”, Neurology, Vol. 43, pp. 13-20, 1993.
Page 13
187
112. Keefe, R.S. and Fenton, W.S. “How should DSM-V criteria for
schizophrenia include cognitive impairment?” Schizophrenia
Bulletin, Vol. 33, No. 4, pp. 912-920, 2007.
113. Kerr, D., Reza, M., Smith, N. and Leatherdale, B.A. “Importance
of insulin in subjective, cognitive, and hormonal responses to
hypoglycemia in patients with IDDM”, Diabetes, Vol. 40,
pp. 1057-1062, 1991.
114. Khaw, K.T., Wareham, N. and Luben, R. “Glycated
haemoglobin, diabetes, and mortality in men in Norfolk cohort of
European Prospective Investigation of Cancer and Nutrition”
(EPIC-Norfolk), British Medical Journal, Vol. 322, pp. 15-18,
2001.
115. Klein, R. “Hyperglycemia and microvascular and macrovascular
disease in diabetes”, Diabetes Care, Vol. 18, No. 2, p. 268, 1995.
116. Kline, M.V. and Linder, M. “Psychodynamic factors in the
experimental investigation of hypnotically induced emotions with
particular reference to blood glucose measurement”,
Psychology, Vol. 71, pp. 21-25, 1969.
117. Knowlesh, C., Guest, G.M., Lampej kesslerm and Skillmant, G.
“The course of juvenile diabetes treated with unmeasured diet”,
Diabetes, Vol. 14, pp. 239-273, 1965.
118. Koch, M.F. and Molnar, G.D. “Psychiatric aspects of unstable
diabetes”, Psychosomatic Medicine, Vol. 36, pp. 57-68, 1974.
119. Koivisto, K., Reinikainen, K., Heninen, T., Vanhanen, M.,
Helkala, E.L., Mykkanen, L., Laakso, M., Pyorala, K. and
Riekkinen, Sr. “Prevalence of age-associated memory impairment
in a randomly selected population from eastern Finland”,
Neurology, Vol. 45, pp. 741-747, 1995.
120. Kramer, A.F., Hahn, S., Cohen, N.J., Banich, M.T., McAuley, E.
and Harrison, C.R. “Ageing, fitness and neurocognitive
function”, Nature, Vol. 400, pp. 418-4199, 1999.
121. Kramer, A.F. and Erickson, K.I. “Effects of physical activity on
cognition, well-being, and brain: human interventions”,
Alzheimer's and Dementia, Vol. 3, pp. 45-51, 2007.
Page 14
188
122. Laakso, M., Reunanen, A., Klaukka, T., Aromaa, A., Maatela, J.
and Pye, K. “Changes in the prevalence and incidence of diabetes
mellitus in Finnish adults”, 1970-1987, American Journal of
Epidemiology, Vol. 133, pp. 850-857, 1991.
123. Labouvie-Vief, G. “Intelligence and cognition”, In: Birren JE,
Schaie KW, eds. Handbook of the Psychology of Aging, New
York: Van Nostrand Reinhold, pp.500-530, 1985.
124. Langa, K.M., Foster, N. and Larson, E.B. “Mixed dementia:
emerging concepts and therapeutic implications”, Journal of the
American Medical Association, Vol. 292, No. 23, pp. 2901-2908,
2004.
125. Lawrence, A.D. and Sahakian, B.J. “Alzheimer disease, attention
and the cholinergic system”, Alzheimer Disease Associated
Disorder, Vol. 9, No. 2, pp. 43-49, 1995.
126. Leon, G.R. “Current directions in the treatment of obesity”,
Psychological. Bulletin, Vol. 83, pp. 557-578, 1976.
127. Ley, P. and Spelmas, S. “Communicating with the Purienr”,
Staples Press, London, 1967.
128. Ley, P., Bradshah, P.W., Eaves, D. and Walker, C.M. “A method
for increasing patients’ recall of information presented by
doctors”, Psychological Medicine, Vol. 3, pp. 217-220, 1973.
129. Lezak, M. “Neuropsychological Assessment, Oxford University
Press, New York, 1995.
130. Li, G., Sokal, I., Quinn, J.F., Leverenz, J.B., Brodey, M. and
Schellenberg, G.D. “CSF tau/Abeta 42 ratio for increased risk of
mild cognitive impairment: a follow-up study”, Neurology,
Vol. 69, No. 7, pp. 631-639, 2007.
131. Lipson, L.G. “Diabetes in the Elderly - Diagnosis, Pathogenesis,
and Therapy”, American Journal of Medicine, Vol. 80, No.5A,
pp. 10-21, 1986.
Page 15
189
132. Loo, S.K., Hopfer, C., Teale, P.D. and Reite, M.L. “EEG
correlates of methylphenidate response in ADHD: association
with cognitive and behavioural measures”, Journal of Clinical
Neurophysiology, Vol. 21, No. 6, pp. 457-464, 2004.
133. Luchsinger, J.A., Reitz, C., Patel, B., Tang, M.X., Manly, J.J.
and Mayeux, R. “Relation of diabetes to mild cognitive
impairment”, Archives of Neurolgia, Vol. 64, No. 4, pp. 570-
575, 2007.
134. Manning, C.A., Hall, J.L., and Gold, P.E. “Glucose effects on
memory and other neuropsychological tests in elderly humans”,
Psychological Science, Vol. 1, pp. 307-311, 1990.
135. Martin, F.I.R. and Warne, G.L. “Factors influencing the
prognosis of vascular disease in insulin-deficient diabetics of long
duration”, A seven-year follow-up. Metabolism, Vol. 24, pp. 1-9,
1975.
136. McCall, A.L. “The impact of diabetes on the CNS”, Diabetes,
Vol. 41, pp. 557-570, 1992.
137. McClelland, G.H. and Judd, C.M. “Statistical difficulties of
detecting interactions and moderator effects”, Psychological
Bulletin, Vol. 114, No. 2, pp. 376-390, 1993.
138. McKhann, G., Drachman, D. and Folstein, M., “Clinical
diagnosis of Alzheimer’s disease: report of the NINCDS-
ADRDA Work Group under the auspices of Department of
Health and Human Services Task Force on Alzheimer’s disease”,
Neurology, Vol. 34, pp. 939-944, 1984.
139. Messier, C. “Impact of impaired glucose tolerance and type 2
diabetes on cognitive aging”, Neurobiology of Aging, Vol. 26,
No. 1, pp. 26-30, 2005.
140. Miles, W.R. and Root, H.F. “Psychologic tests applied to diabetic
patients”, Archieves of Internal Medicine, Vol. 30, pp. 767-777,
1922.
Page 16
190
141. Morris, J.C., Storandt, M., Miller, J.P., McKeel, D.W., Price, J.L.
and Rubin, E.H. “Mild cognitive impairment represents early-
stage Alzheimer disease”, Archieves of Internal Medicine,
Vol. 58, No. 3, pp. 397-405, 2001.
142. Morris, M.C., Evans, D.A. and Tangney, C.C. “Associations of
vegetable and fruit consumption with age-related cognitive
change”, Neurology, Vol. 67, pp. 1370-1376, 2006.
143. Munshi, M., Grande, L., Hayes, M., Ayres, D., Suhl, E.,
Capelson, R., Lin, S., Milberg, W. and Weinger, K. “Cognitive
dysfunction is associated with poor diabetes control in older
adults”, Diabetes Care, Vol. 29, pp. 1794- 1799, 2006.
144. Murray, I. and Wang, I. “A comparison of dbese and non-obese
diabetic subjects”, Diabetes, Vol. 5, pp. 48-52, 1956.
145. Mykken, L., Laakso, M., Uusitupa, M. and Pya, K. “Prevalence
of diabetes and impaired glucose tolerance in elderly subjects and
their association with obesity and family history of diabetes”,
Diabetes Care, Vol. 13, pp. 1099-1105, 1990.
146. Nash, D.T. and Fillit, H. “Cardiovascular disease risk factors and
cognitive impairment”, American Journal of Cardiology, Vol. 97,
pp. 1261-1265, 2006.
147. Oei, Y., Everaerd, W.T., Elzinga, B.M., Van Well, S. and
Bermond, B. “Psychosocial stress impairs working memory at
high loads: An association with cortisol levels and memory
retrieval”, Stress, Vol. 9, No. 3, pp. 133-14, 2006.
148. Ohlsson, L.O., Larsson, B., Eriksson, H., Svdsudd, K., Welin, L.
and Tibblin, G. “Diabetes mellitus in Swedish middle-aged men.
The study of men born in 1913 and 1923”, Diabetologia, Vol. 30,
pp. 386-393, 1987.
149. Okereke MD, Olivia I,Jae H. Kang ScD, Nancy R. Cook ScD, J.
Michael Gaziano MD, JoAnn E. Manson MD, DrPH, Julie E.
Buring ScD, Francine Grodstein ScD, “Type 2 Diabetes Mellitus
and Cognitive Decline in Two Large Cohorts of Community-
Dwelling Older Adults”, Journal of the American Geriatrics
Society, Vol. 56, No. 6, pp. 1028-1036, June 2008.
Page 17
191
150. Palovick, R.A., Phillips, M.I., Kappy, M.S., and Raizada, M.K.
“Insulin inhibits pyramidal neurons in hippocampal slices”, Brain
Research, Vol. 309, pp. 187-191, 1984.
151. Par, C.R. “Cognitive effects of insulin in the central nervous
system”, Neuroscience and Biobehavioral Reviews, Vol. 25,
No. 4, pp. 311-323, 2001.
152. Perlmutter, M., Adams, C., Berry, J., Kaplan, M., Person, D. and
Verdonik, F. “Aging and memory”, In: Schaie KW, Annual
Review of Gerontology and Geriatrics, New York, Springer,
Vol. 7, pp. 57-92, 1987.
153. Petersen, R.C., Doody, R., Kurz, A., Mohs, R.C., Morris, J.C. and
Rabins, P.V. “Current concepts in mild cognitive impairment”,
Archives of Neurology, Vol. 58, No. 12, pp. 1985-1992, 2001.
154. Petersen, R.C. “Mild cognitive impairment as a diagnostic
entity”, Journal of Internal Medicine, Vol. 256, No. 3, pp. 183-
194, 2004.
155. Petersen, R.C., Smith, G.E., Waring, S.C., Ivnik, R.J., Tangalos,
E.G. and Kokmen, E. “Mild cognitive impairment: clinical
characterization and outcome”, Archives of Neurology, Vol. 56,
No. 3, pp. 303-308, 1999.
156. Petersen, R.C., Smith, G.E., Waring, S.C., Ivnik, R.J., Kokmen,
E. and Tangelos, E.G. “Aging, memory, and mild cognitive
impairment”, Internal Psychogeriatrics, Vol. 9, No. 1, pp. 65-69,
1997.
157. Petersonc, M., Jonesr, L., Dupuis, A., Bernsteinr and O’ Sheam
“Feasibility of tight control of juvenile diabetes through patient
monitored glucose determinations”, Paper presented to the
American Diabetes Association, 1978.
158. Pya, K., Laakso, M. and Uusitupa, M. “Diabetes and
atherosclerosis: an epidemiological view”, Diabetes Metabolic
Review, Vol. 3, No. 2, pp. 464-524, 1987.
Page 18
192
159. Raichle, M.E., Herscovitch, P., Mintun, M., Martin, W.R. and
Powers, W. “Dynamic measurements in the study of higher
cortical function in humans with positron emission tomography”,
Annual of Neurology, Vol. 15, pp. 48-49, 1984.
160. Ramachandran, A., Snehalatha, C., Kapur, A., Vijay, V., Mohan,
V., Das, A.K., Rao, P.V., Yajnik, C.S., Prasanna Kumar, K.M.
and Jyotsna, D. The Diabetes Epidemiology Study Group in India
(DESI): “High prevalence of diabetes and impaired glucose
tolerance in India: National Urban Diabetes Survey”,
Diabetologia, Vol. 44, pp. 1094-1101, 2001.
161. Reaven, G.M., Thompson, L.W., Nahum, D. and Haskins, E.
“Relationship between hyperglycemia and cognitive function in
older NIDDM patients”, Diabetes Care, Vol. 13, pp. 16-20, 1990.
162. Reichard, Bengt-Yngve Nilsson, and Urban Rosenqvist. “The
Effect of Long-Term Intensified Insulin Treatment on the
Development of Microvascular Complications of Diabetes
Mellitus”, New England Journal of Medicine, Vol. 329, pp. 304-
309, 1993.
163. Riedel, O., Klotsche, J., Spottke, A., Deuschl, G., Forstl, H. and
Henn, F. “Cognitive impairment in 873 patients with idiopathic
Parkinson's disease. Results from the German Study on
Epidemiology of Parkinson's Disease with Dementia” (GEPAD),
Journal of Neurolgia, Vol. 255, No. 2, pp. 255-264, 2008.
164. Ritchie, K., Artero, S. and Touchon, J. “Classification criteria for
mild cognitive impairment: a population-based validation study”,
Neurology, Vol. 56, No. 1, pp. 37-42, 2001.
165. Roca, M., Torralva, T., Meli, F., Fiol, M., Calcagno, M.L. and
Carpintiero, S. “Cognitive deficits in multiple sclerosis correlate
with changes in fronto-subcortical tracts”, Multiple Sclerosis,
Vol. 14, No. 3, pp. 364-369, 2008.
166. Rosen, H. and Lidz, T. “Emotional factors in the precipitation of
recurrent diabetic acidosis”, Psychosomatic Medicine, Vol. 11,
pp. 211-215, 1949.
Page 19
193
167. Ryan, C.M. and Geckle, M.O. “Circumscribed cognitive
dysfunction in middle-aged adults with type 2 diabetes”, Diabetes
Care, Vol. 23, pp. 1486-1493, 2000.
168. Sanders, K., Mills, J., Martin, F.I.R., Horned, J. and De, L.
“Emotional attitudes in adult insulin dependent diabetes”, Journal
of psychosomal Research, Vol. 19, pp. 241-246, 1975.
169. Sanisoglu, S., Cagatay Oktenli, Adnan Hasimi, Mehmet
Yokusoglu and Mehmet Ugurlu “Prevalence of metabolic
syndrome-related disorders in a large adult population in
Turkey”, BMC Public Health, 6:92, doi:10.1186/1471-2458-6-92,
2006.
170. Scarmeas, N. and Stern, Y. “Cognitive reserve and lifestyle”,
Journal of Clinical and Experimental Neuropsychology, Vol. 25,
pp. 625-633, 2003.
171. Schmidtke, K. and Hermeneit, S. “High rate of conversion to
Alzheimer's disease in a cohort of amnestic MCI patients”,
International Psychogeriatrics, Vol. 20, No. 01, pp. 96-108, 2007.
172. Schoonenboom, S.N., Visser, P.J., Mulder, C., Lindeboom, J.,
Van Elk, E.J. and Van Kamp, G.J. “Biomarker profiles and their
relation to clinicalvariables in mild cognitive impairment”,
Neurocase, Vol. 11, No.1, pp. 8-13, 2005.
173. Schuit, A.J., Feskens, E.J., Launer, L.J. and Kromhout, D.
“Physical activity and cognitive decline, the role of the
apolipoprotein e4 allele”, Medicine and Science in Sports and
Exercise, Vol. 33, No. 5, pp. 772-777, 2001.
174. Schulingkamp, R.J., Pagano, T.C., Hung, D. and Raffa, R.B.
“Insulin receptors and insulin action in the brain: review and
clinical implications”, Neuroscience and Biobehavioral Reviews,
Vol. 24, No. 8, pp. 855-872, 2000.
175. Seyfaddini Rostam “Cognitive function in diabetes mellitus
patients”, American Journal of Applied Sciences, Vol. 3, No. 1,
pp. 1682-1684, 2006.
Page 20
194
176. Shibata, S., Liou, S.Y., Ueki, S. and Oomura, Y. “Inhibitory
action of insulin on suprachiasmatic nucleus neurons in rat
hypothalamic slice preparation”, Physiological Behaviour,
Vol. 36, pp. 79-81, 1985.
177. Simonds, J.F. “Psychiatric status of diabetic youth in good and
poor control”, The International Journal of Psychiatry in
Medicine, Vol. 7, pp. 133-151, 1977.
178. Skyler, J.S. “Diabetic complications: The importance of glucose
control”, Endocrinology and Metabolism Clinics of North
America, Vol. 25, pp. 243-245, 1996.
179. Sloane, P.D., Zimmerman, S. and Suchindran, C. “The public
health impact of Alzheimer's disease, 2000-2050: potential
implication of treatment advances”, Annual Review of Public
Health, Vol. 23, pp. 213-231, 2002.
180. Sowers, J.R., Epstein, M. and Frohlich, E.D. “Diabetes,
Hypertension, and Cardiovascular Disease: An Update”,
Hypertension, Vol. 37, No. 4, pp. 1053-1059, 2001.
181. Spiegel, A.D. “Programmed instructional materials for patient
education”, Journal of Medical Education, Vol. 42, pp. 958-962,
1967.
182. Squire, L.R. and Knowlton, B.J. “Memory, hippocampus, and
brain systems”, In M. S. Gazzaniga (Ed.), the cognitive
neurosciences. Cambridge, MA: MIT Press., pp. 825-837, 1995.
183. Squire, L.R. “Memory and the hippocampus: a synthesis of
findings with rats, monkeys and humans”, Psychological Review,
Vol. 99, No. 2, pp. 195-231, 1992.
184. Stearns, S. “Self-destructive behaviour in young patients with
diabetes mellitus”, Diabetes, Vol. 8, pp. 379-382, 1959.
185. Stern, M.P. Kelly West Lecture, “Primary prevention of typeII
diabetes mellitus”, Diabetes Care, Vol. 14, pp. 399-410, 1991.
186. Stern, M.P. “Diabetes and cardiovascular disease. The common
soil hypothesis”, Diabetes, Vol. 44, pp. 369-374, 1995.
Page 21
195
187. Stewart, R. and Liolitsa, D. “Type 2 diabetes mellitus, cognitive
impairment and dementia”, Diabetic Medicine, Vol. 16, No. 2,
pp. 93-112, February 1999.
188. Stone, W.S., Walsher, B., Gold, S.D. and Gold, P.E.
“Scopolamine and morphine-induced impairment of spontaneous
alternation performance in mice: reversal with glucose and with
cholinergic and adrenergic agonists”, Behavioral Neuroscience,
Vol. 105, pp. 264-272, 1991.
189. Stone, D.B. “A study of the incidence and causes of poor control
in patients with diabetes mellitus”, American Journal of
Medicinal Science, Vol. 241, pp. 436-441, 1961.
190. Strachan, M.W., Reynolds, R.M., Frier, B.M., Mitchell, R.J. and
Price, J.F. “The relationshipbetween type 2 diabetes and
dementia”, British Medical Bulletin, Vol. 88, No. 1, pp. 131-146,
2008.
191. Strachan, M.W.J., Deary, I.J., Ewing F.M.E. and Frier, B.M. “Is
type II diabetes associated with an increased risk of cognitive
dysfuction?” Diabetes Care, Vol. 20, pp. 438-445, 1997a.
192. Strachan, M.W.J., Frier, B.M. and Deary, I.J. “Cognitive
assessment in diabetes: the need for consensus”, Diabetic
Medicines, Vol. 14, pp. 421-422, 1997b.
193. Sulway, M. “Patient compliance and treatment outcome in
diabetes”, Paper given at King’s College Hospital, London, 30
June, 1977.
194. Swihart, A.A. and Prinzzolo, F.J. “The neuropsychokogy of aging
and dementia: Clinical issues”, Neuropsychological Studies of
Nonfocal Brain Damage, New York, Springer; Vol. 1, pp. 15,
1988.
195. Tabert, M.H., Manly, J.J., Liu, X., Pelton, G.H., Rosenblum, S.
and Jacobs, M. “Neuropsychological prediction of conversion to
Alzheimer disease in patients with mild cognitive impairment”,
Archieves of General Psychiatry, Vol. 63, No. 8, pp. 916-924,
2006.
Page 22
196
196. Tani, G.S. and Hankin, J.H. “A self-learning, unit for patients
with diabetes”, Journal of American Diet Association, Vol. 4,
No. 58, pp. 331-335, 1971.
197. Teng, E.L. and Chui, H.C. “The Modified Mini-Mental State
(3MS) Examination”, Journal of Clinical Psychiatry, Vol. 48,
pp. 314-318, 1987.
198. Teng, E.L., Hasegawa, K. and Homma, A. “The Cognitive
Abilities Screening Instrument (CASI) : a practical test for cross-
cultural epidemiologic studies of dementia”, Internal
Psychogeriatry, Vol. 6, pp. 45-56, 1994.
199. Thoresenc, E. and Mahoneym, J. “Behavioural Self Control”,
Holt-Rinehart, New York, 1974.
200. Tierney, M.C., Szalai, J.P., Snow, W.G., Fisher, R.H., Nores, A.
and Nadon, G. “Prediction of probable Alzheimer's disease in
memory-impaired patients: A prospective longitudinal study”,
Neurology, Vol. 46, No. 3, pp. 661-665, 1996.
201. Treutingt, F. “The role of emotional factors in the etiology and
course of diabetes mellitus: A review of the recent literature”,
American Journal of Medical Science, Vol. 244, pp. 92-109,
1962.
202. Tuneridger, E. “Sociomedical aspects of diabetes mellitus”,
Lancet, Vol. 2, pp. 893-899, 1953.
203. Unger, J.W., Livingston, J.N. and Moss, A.M. “Insulin receptors
in the centralnervous system: localization, signalling mechanisms
and functional aspects”, Progress in Neurobiology, Vol. 36,
No. 5, pp. 343-362, 1991.
204. Van Duijn, C.M. “Epidemiology of the dementias: recent
developments and new approaches”, Journal Neurology,
Neurosurgery and Psychiatry, Vol. 60, pp. 478-488, 1996.
205. Van Gelder, B.M., Tijhuis, M.A.R., Kalmijn, S., Giampaoli, S.,
Nissinen, A. and Kromhout, D. “Physical activity in relation to
cognitive decline in elderly men: the FINE Study”, Neurology,
Vol. 63, pp. 2316-2321, 2004.
Page 23
197
206. Vandenbergrh, L., Sussmank, E. and Titus, C.C. “Effects of
hypnotically induced acute emotional stress on carbohydrate and
liquid metabolism in patients with diabetes mellitus”,
Psychosomatic Medicine, Vol. 28, pp. 382-390, 1966.
207. Vogels, R.L., Oosterman, J.M., van Harten, B., Scheltens, P., van
der Flier, W.M. and Schroeder-Tanka, J.M. “Profile of cognitive
impairment in chronic heart failure”, Journal of the American
Geriatrics Society, Vol. 55, No. 11, pp. 1764-1770, 2007.
208. Wahlin, A., Hill, R.D., Winblad, B. and Backman, L. “Effects of
serum vitaminB12 and folate status on episodic memory
performance in very old age: a population-based study”,
Psychology and Aging, Vol. 11, No. 3, pp. 487-496, 1996.
209. Wahlin, A. “Health, disease, and cognitive functioning in old
age”, In R. A. Dixon, L. Backman and Nilsson, L.G. (Eds.), New
frontiers in cognitive aging, Oxford, UK: Oxford University
Press, pp. 279-302, 2004.
210. Waldstein, S.R., Rice, S.C., Thayer, J.F., Najjar, S.S., Scuteri, A.
and Zonderman, A.B. “Pulse pressure and pulse wave velocity
are related to cognitive decline in the Baltimore Longitudinal
Study of Aging”, Hypertension, Vol. 51, pp. 99-104, 2008.
211. Wallum, B.J., Taborsky, G.J., Porte, D., Figlewiczm D.P.,
Jacobson, L. and Beard, J.C. “Cerebrospinal fluid insulin levels
increase during intravenous insulin infusions in man”, Journal of
clinical endocrinology and metabolism, Vol. 64, No. 1, pp. 190-
194, 1987.
212. Watkins, J.D., Robertsd, E., Williamst, F., Martin, D.A. and
Coylev “Observation of medication errors made by diabetic
patients in the home”, Diabetes, Vol. 16, pp. 882-885, 1967a.
213. Watkins, J.D., Williamst, F., Martin, D.A., Hogan, M.D. and
Andersone “A study of diabetic patients at home”, American
Journal of Public Health and Nations Health, Vol. 57, pp. 452-
459, 1967b.
214. Watson, G.S. and Craft, S. “Insulin resistance, inflammation, and
cognition in Alzheimer's Disease: Lessons for multiple sclerosis”,
Journal of the Neurological Sciences, 2006.
Page 24
198
215. Wenk, G.L. “An hypothesis on the role of glucose in the
mechanism of action of cognitive enhancers”,
Psychopharmacology, Vol. 99, pp. 431-438, 1981.
216. West, K.M. “Diet therapy of diabetes. An analysis of failure”,
Annuals of Internal Medicine, Vol. 79, pp. 425-434, 1973.
217. Weuve, J., Kang, J.H., Manson, J.E., Breteler, M.M.B, Ware, J.H.
and Grodstein, F. “Physical activity, including walking, and
cognitive function in older women”, Journal of American
Medical Association, Vol. 292, pp. 1454-1461, 2004.
218. Williams, G. and Pickup, J.C. Handbook of diabetes (3 ed.),
Malden, MA:Blackwell Publication, 2004.
219. Williamst, F., Martind, A., Hogan, M.D., Watkinsj, F. and Ellis,
E. “The clinical picture of diabetic control, studied in four
settings”, American Journal of Public Health and the Nations
Health, Vol. 57, pp. 441-451, 1967.
220. Wilson, R.S., Schneider, J.A., Boyle, P.A., Arnold, S.E., Tang, Y.
and Bennett, D.A. “Chronic distress and incidence of mild
cognitive impairment”, Neurology, Vol. 68, No. 24, pp. 2085-
2092, 2007.
221. Winblad, B., Palmer, K., Kivipelto, M., Jelic, V., Fratiglioni, L.,
Wahlund, L.O. “Mild cognitive impairment--beyond
controversies, towards a consensus: report of the International
Working Group on Mild Cognitive Impairment”, Journal of
Internal Medicine, Vol. 256, No. 3, pp. 240-246, 2004.
222. Wolf-Maier, K., Cooper, R.S., Banegas, J.R., Giampaoli, S.,
Hense, H.W. and Joffres, M. “Hypertension prevalence and blood
pressure levels in European countries, Canada, and the United
States”, Journal of the American Medical Association, Vol. 289,
No. 18, pp. 2363-2369, 2003.
223. World Health Organization “WHO study group on diabetes
mellitus. Technical Report. Series 727, Geneva”, World Health
Organization, 1985.
Page 25
199
224. Worrall, G., Moulton, N. and Briffett, E. “Effect of type II
diabetes mellitus on cognitive function”, The Journal of Family
Practice, Vol. 36, pp. 639-643, 1993.
225. Yaffe, K., Barnes, D., Nevitt, M., Lui, L.Y., Covinsky, K. “A
prospective study of physical activity and cognitive decline in
elderly women: women who walk”, Archives of Internal
Medicine, Vol. 161, pp. 1703-1708, 2001.
226. Yeung, Sophie E., Fischer, Ashley L., Dixon and Roger, A.
“Exploring Effects of Type 2 Diabetes on Cognitive Functioning
in Older Adults”, Neuropsychology, Vol. 23, No. 1, pp. 1, 2009.
227. Young, C.M. and Trulson, M.F. “Methodology for dietary studies
in epidemiological survey s.II. Strengths and weaknesses in
existing methods”, American Journal of Public Health, Vol. 50,
pp. 803-814, 1960.
228. Zimmet, P., Alberti, K.G. and Shaw, J. “Global and societal
implications of thediabetes epidemic”, Nature, Vol. 414,
No. 6865, pp. 782-787, 2001.
229. Zola-Morgan, S. and Squire, L.R. “Neuroanatomy of memory”,
Annual Review of Neuroscience, Vol. 16, pp. 547-563, 1993.